The effect of intravenous magnesium sulfate and succinylcholine in resection bladder tumor surgery.
Phase 2
Recruiting
- Conditions
- Bladder tumor.Malignant neoplasm of bladder
- Registration Number
- IRCT20130812014333N152
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Patients with ASA Class1,2
Patients are candidates for bladder tumor resection through the urethra
Exclusion Criteria
Kidney failure with GFR <45 ml / min
Heart failure, heart rhythm disturbances, calcium and magnesium plasma disorders, hemodynamic disorders
Taking drugs that affect calcium and magnesium transfer in muscle
Musculoskeletal Diseases
Hemodynamic instability
Taking medications that affect the transmission of neuromuscular messages
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Muscular pain. Timepoint: The first 24 hours after surgery. Method of measurement: Using the NRS method (numerically from 0 to 10).
- Secondary Outcome Measures
Name Time Method